| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/SYN.20949 |
| P8608 | Fatcat ID | release_yl5xu43nwfcyhflzfb2ica3zsq |
| P932 | PMC publication ID | 3676522 |
| P698 | PubMed publication ID | 21538554 |
| P5875 | ResearchGate publication ID | 51094509 |
| P50 | author | Rosemarie M Booze | Q59690860 |
| P2093 | author name string | Jun Zhu | |
| Charles F Mactutus | |||
| Subramaniam Ananthan | |||
| P2860 | cites work | Dopamine uptake inhibitors but not dopamine releasers induce greater increases in motor behavior and extracellular dopamine in adolescent rats than in adult male rats | Q34214735 |
| Estrogen attenuates gp120- and tat1-72-induced oxidative stress and prevents loss of dopamine transporter function | Q34461323 | ||
| Microarray analysis of cutaneous squamous cell carcinomas reveals enhanced expression of epidermal differentiation complex genes | Q36765030 | ||
| Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS | Q36856162 | ||
| Studies of the biogenic amine transporters. 12. Identification of novel partial inhibitors of amphetamine-induced dopamine release. | Q36926340 | ||
| HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes | Q37196323 | ||
| Intra-accumbal Tat1-72 alters acute and sensitized responses to cocaine | Q37244423 | ||
| Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse | Q37314434 | ||
| Human immunodeficiency virus-associated neurocognitive disorder: pathophysiology in relation to drug addiction | Q37702353 | ||
| Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding | Q42287558 | ||
| Identification and characterization of a novel allosteric modulator (SoRI-6238) of the serotonin transporter | Q44965402 | ||
| Decreased brain dopaminergic transporters in HIV-associated dementia patients | Q45023437 | ||
| [3H]WIN 35,428 binding to the dopamine uptake carrier. II. Effect of membrane fractionation procedure and freezing | Q48201176 | ||
| Detection of HIV-1 Tat and JCV capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy | Q73949738 | ||
| P433 | issue | 11 | |
| P304 | page(s) | 1251-1254 | |
| P577 | publication date | 2011-05-17 | |
| P1433 | published in | Synapse | Q7662025 |
| P1476 | title | Recombinant human immunodeficiency virus-1 transactivator of transcription1-86 allosterically modulates dopamine transporter activity | |
| P478 | volume | 65 |
| Q30452291 | Adolescent HIV-1 transgenic rats: evidence for dopaminergic alterations in behavior and neurochemistry revealed by methamphetamine challenge |
| Q33808035 | Allosteric modulatory effects of SRI-20041 and SRI-30827 on cocaine and HIV-1 Tat protein binding to human dopamine transporter. |
| Q40182651 | D1/NMDA receptors and concurrent methamphetamine+ HIV-1 Tat neurotoxicity |
| Q35559749 | Didehydro-cortistatin A inhibits HIV-1 Tat mediated neuroinflammation and prevents potentiation of cocaine reward in Tat transgenic mice |
| Q47432196 | Dose-dependent neurocognitive deficits following postnatal day 10 HIV-1 viral protein exposure: Relationship to hippocampal anatomy parameters. |
| Q37409631 | Effects of conditional central expression of HIV-1 tat protein to potentiate cocaine-mediated psychostimulation and reward among male mice |
| Q41542010 | Estrous cycle and HIV-1 Tat protein influence cocaine-conditioned place preference and induced locomotion of female mice. |
| Q38812005 | HIV, Tat and dopamine transmission. |
| Q36944251 | HIV-1 Tat protein decreases dopamine transporter cell surface expression and vesicular monoamine transporter-2 function in rat striatal synaptosomes |
| Q47105825 | HIV-1 and cocaine disrupt dopamine reuptake and medium spiny neurons in female rat striatum. |
| Q35743630 | HIV-1 proteins, Tat and gp120, target the developing dopamine system |
| Q37672037 | HIV-1 transgenic rats display an increase in [(3)H]dopamine uptake in the prefrontal cortex and striatum. |
| Q35007339 | Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors |
| Q89796139 | Male HIV-1 transgenic rats show reduced cocaine-maintained lever-pressing compared to F344 wildtype rats despite similar baseline locomotion |
| Q34034134 | Modeling deficits in attention, inhibition, and flexibility in HAND. |
| Q35450098 | Molecular mechanism of HIV-1 Tat interacting with human dopamine transporter |
| Q37501478 | Molecular mechanism: the human dopamine transporter histidine 547 regulates basal and HIV-1 Tat protein-inhibited dopamine transport |
| Q34343025 | Mutation of tyrosine 470 of human dopamine transporter is critical for HIV-1 Tat-induced inhibition of dopamine transport and transporter conformational transitions. |
| Q64054571 | Mutational effects of human dopamine transporter at tyrosine88, lysine92, and histidine547 on basal and HIV-1 Tat-inhibited dopamine transport |
| Q34458860 | Mutations at tyrosine 88, lysine 92 and tyrosine 470 of human dopamine transporter result in an attenuation of HIV-1 Tat-induced inhibition of dopamine transport. |
| Q30399828 | Neonatal intrahippocampal HIV-1 protein Tat(1-86) injection: neurobehavioral alterations in the absence of increased inflammatory cytokine activation |
| Q30445058 | Neurobehavioral alterations in HIV-1 transgenic rats: evidence for dopaminergic dysfunction |
| Q36164951 | Prefrontal dopaminergic and enkephalinergic synaptic accommodation in HIV-associated neurocognitive disorders and encephalitis |
| Q33795961 | Progesterone protects normative anxiety-like responding among ovariectomized female mice that conditionally express the HIV-1 regulatory protein, Tat, in the CNS. |
| Q52654834 | Scaling Synapses in the Presence of HIV. |
| Q38803243 | Selective Vulnerability of Striatal D2 versus D1 Dopamine Receptor-Expressing Medium Spiny Neurons in HIV-1 Tat Transgenic Male Mice. |
| Q26777952 | The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders |
| Q41922188 | The role of human dopamine transporter in NeuroAIDS. |
| Q30431943 | Time and time again: temporal processing demands implicate perceptual and gating deficits in the HIV-1 transgenic rat. |
| Q38217388 | Viral and cellular factors underlying neuropathogenesis in HIV associated neurocognitive disorders (HAND) |
Search more.